Evidence map›Paper›PMID 41607534›Full record

ArticleFrontiers in oncology2025

Case Report: Pediatric AML with

Qiang Yao, Xiaoyong Chen, Meizhu Luo, Zhenhu Lin, Xiaoying Fu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiang Yao *Department of Laboratory Medicine, Shenzhen Children's Hospital, Affiliated to Shantou University Medical College, Shenzhen, Guangdong, China.
Xiaoyong Chen *Department of Hematology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, Guangdong, China.
Meizhu LuoDepartment of Laboratory Medicine, Shenzhen Children's Hospital, Affiliated to Shantou University Medical College, Shenzhen, Guangdong, China.
Zhenhu LinDepartment of Laboratory Medicine, Shenzhen Children's Hospital, Affiliated to Shantou University Medical College, Shenzhen, Guangdong, China.
Xiaoying FuDepartment of Laboratory Medicine, Shenzhen Children's Hospital, Affiliated to Shantou University Medical College, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a diagnostically challenging case of acute myeloid leukemia (AML) in a 2-year-9-month-old boy, presenting with diarrhea and pancytopenia. Bone marrow aspiration revealed 90% blasts exhibiting cup-like nuclei and azurophilic granules, morphologically mimicking acute promyelocytic leukemia (APL).However, immunophenotyping was inconsistent with classic APL, showing positivity for CD33 and cytoplasmic myeloperoxidase (cMPO) but negativity for CD34 and HLA-DR. Molecular analysis was negative for the canonical PML::RARA fusion but identified a rare

Indexed as

acute myeloid leukemia (AML)APLdiagnostic pitfallsFLT3-ITD/NPM1 co-mutationTBC1D15::RAB21 fusion gene

Identifiers

PMID41607534
PMCPMC12834770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.